Canadian drugmaker Valeant agrees to buy US rival Salix for about $10 billion in cash

Canadian drugmaker Valeant Pharmaceuticals International Inc. has agreed to buy Salix Pharmaceuticals Ltd. for about $10 billion in cash.



from RSSMix.com Mix ID 7907849 http://ift.tt/1AksXtA via gold ira